- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04457128
Real-time Behavioral Interventions
November 5, 2020 updated by: University of Alabama, Tuscaloosa
Just-in-Time Adaptive Intervention to Reduce Sedentary Behavior
The goal of this study is to adapt an evidence-based sedentary behavior reduction intervention for men and women living in Alabama and determine its feasibility, acceptance, and limited efficacy.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
The goal of this study is to adapt an evidence-based sedentary behavior reduction intervention for men and women living in Alabama and determine its feasibility, acceptance, and limited efficacy.
Community-based Participatory Research methods will be used to adapt an evidence-based curriculum.
The adapted curriculum will be delivered via print-based materials and a mobile phone app developed by an external collaborator.
Study Type
Interventional
Enrollment (Anticipated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 75 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
• 50 to 75 years old at study enrollment;
- Currently living in Alabama;
- Community-dwelling (i.e., not living in an assisted living facility or nursing home);
- Having access to the internet and a smart phone;
- Able to perform light-intensity physical activity (i.e., walking);
- English speaking;
- Willing to consent to study procedure.
Exclusion Criteria:
- Reporting more than 60 minutes of purposeful physical activity per week;
- Have an unstable mental condition that prevention study activities. Determined by the Physician Health questionnaire.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: FACTORIAL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Secular Image
|
Randomized factorial design
|
|
EXPERIMENTAL: Non-secular image
non-secular images
|
Randomized factorial design
|
|
EXPERIMENTAL: Secular message
secular messages
|
Randomized factorial design
|
|
EXPERIMENTAL: Non-secular message
non-secular messages
|
Randomized factorial design
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Usage
Time Frame: 16 weeks
|
To percentage of time participants were complying with the study protocol
|
16 weeks
|
|
The Usage, Satisfaction, Ease of use Questionnaire
Time Frame: 16 weeks
|
Questionnaire that assesses usage, satisfaction, and ease of use of technology.
Each subscale has a maximum score of 20, with higher scores indicating a better outcome.
|
16 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in sedentary time
Time Frame: Week 0 and Week 16
|
Accelerometer determined breaks in inactivity during waking hours
|
Week 0 and Week 16
|
|
Change in light-intensity physical activity
Time Frame: Week 0 and Week 16
|
Accelerometer determined activity
|
Week 0 and Week 16
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
January 1, 2021
Primary Completion (ANTICIPATED)
June 30, 2021
Study Completion (ANTICIPATED)
August 31, 2021
Study Registration Dates
First Submitted
April 3, 2020
First Submitted That Met QC Criteria
June 29, 2020
First Posted (ACTUAL)
July 7, 2020
Study Record Updates
Last Update Posted (ACTUAL)
November 9, 2020
Last Update Submitted That Met QC Criteria
November 5, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 20-03-3472
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
No at this time
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
Second Affiliated Hospital of Soochow UniversityNot yet recruitingCancer | Solid Cancer
-
New Mexico Cancer Research AllianceOhio State University Comprehensive Cancer Center; H. Lee Moffitt Cancer Center...RecruitingCancer | Cancer RiskUnited States
-
Children's Hospital of PhiladelphiaCompletedCancer | Childhood CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
UNICANCERRecruitingAdvanced Breast Cancer | Advanced Gastric Cancer | Advanced Urothelial Cancer | Advanced Non Small Cell Lung Cancer (NSCLC)France
Clinical Trials on Just-in-Time Adaptive Intervention
-
Wageningen University and ResearchZonMw: The Netherlands Organisation for Health Research and DevelopmentCompleted
-
University of MichiganNational Institute on Drug Abuse (NIDA)Completed
-
University of ZurichRecruitingDepressive Symptoms | Loneliness | Social SupportSwitzerland
-
University of MichiganNational Institute of Nursing Research (NINR)CompletedCaregiversUnited States
-
University of MichiganNational Center for Advancing Translational Sciences (NCATS)CompletedCaregiversUnited States
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI)CompletedHypertension | Blood PressureUnited States
-
Trustees of Dartmouth CollegeNot yet recruitingAnxiety Disorders | Anxiety | Anxiety Disorder of Childhood
-
Chinese University of Hong KongNot yet recruitingSleep and Circadian ProblemsHong Kong
-
Chinese University of Hong KongNot yet recruitingSleep and Circadian ProblemsHong Kong
-
Colliga Apps Corp.National Institute of Mental Health (NIMH)CompletedFamily Functioning | Mental Health and Well-beingUnited States